Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals has disclosed Accumulated Expenses across 4 years of filings, most recently posting $572865.0 for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $572865.0, up 90.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $572865.0 (up 90.96% YoY), and the FY2025 annual result was $572865.0, up 90.96% from the prior year.
• Accumulated Expenses came in at $572865.0 for Q4 2025 at Mira Pharmaceuticals, up from $5500.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $572865.0 in Q4 2025 to a low of $5500.0 in Q1 2025.
• The 4-year median for Accumulated Expenses is $14472.0 (2023), against an average of $136042.3.
• Across the five-year window, Accumulated Expenses soared 1972.97% in 2024 and tumbled 62.0% in 2025, its largest moves.
• Mira Pharmaceuticals' Accumulated Expenses stood at $34987.0 in 2022, then sank by 58.64% to $14472.0 in 2023, then jumped by 1972.97% to $300000.0 in 2024, then soared by 90.96% to $572865.0 in 2025.
• The last three Accumulated Expenses figures came in at $572865.0 (Q4 2025), $5500.0 (Q1 2025), and $300000.0 (Q4 2024), per Business Quant data.